Skip to main content

Table 1 Baseline characteristics

From: Outcome of patients with double valve surgery between 2009 and 2018 at University Hospital Basel, Switzerland

 

DVR (N = 41)

AVR + MVP (N = 48)

p

Age

65 [57 to 72]

68 [62 to 75]

0.18

Age ≥ 70 years

13 (32%)

18 (38%)

0.66

Gender

  

0.34

Female

14 (34%)

11 (23%)

 

Male

27 (66%)

37 (77%)

 

EuroSCORE II

4.6 [2.8 to 12]

5.9 [2.9 to 12]

0.67

Comorbidities

   

Vascular disease

9 (22%)

5 (10%)

0.13

Diabetes

5 (12%)

6 (13%)

0.96

COPD

4 (10%)

1 (2%)

0.11

Kidney disease

13 (31%)

18 (38%)

0.56

Atrial fibrillation

20 (49%)

29 (60%)

0.27

Hypertension

8 (20%)

14 (29%)

0.29

Obesity

7 (17%)

5 (10%)

0.36

Hepatic cirrhosis

2 (5%)

0%

0.20

AV_etiology

  

0.002

Degenerative

15 (37%)

34 (71%)

 

Congenital

1 (2.4%)

1 (2.1%)

 

Paravalvular leak

0 (0.00%)

1 (2.1%)

 

Rheumatic

7 (17%)

1 (2.1%)

 

Endocarditis

18 (44%)

11 (23%)

 

 Active endocarditis

13 (72%)

7 (64%)

0.63

 Chronic endocarditis

5 (28%)

4 (36%)

0.63

AV_disease

  

0.10

Stenosis

6 (15%)

13 (27%)

 

Regurgitation

31 (76%)

27 (56%)

 

Combined

4 (10%)

4 (8.3%)

 

Abscess

0 (0.00%)

4 (8.3%)

 

MV_etiology

  

 < 0.001

Degenerative

13 (32%)

36 (75%)

 

Congenital

1 (2.4%)

1 (2.1%)

 

Rheumatic

7 (17%)

1 (2.1%)

 

Iatrogenic

1 (2.4%)

0 (0.00%)

 

Endocarditis

19 (46%)

10 (21%)

 

MV_disease

  

0.25

Regurgitation

41 (100%)

44 (92%)

 

Abscess

0 (0.00%)

3 (6.3%)

 

Perforation

0 (0.00%)

1 (2.1%)